Posttraumatic stress disorder treatment: Genetic predictor of response to exposure therapy

From a new study in Biological Psychiatry

2013-06-11

(Press-News.org) Philadelphia, PA, June 11, 2013 – There is growing evidence that a gene variant that reduces the plasticity of the nervous system also modulates responses to treatments for mood and anxiety disorders. In this case, patients with posttraumatic stress disorder, or PTSD, with a less functional variant of the gene coding for brain-derived neurotrophic factor (BDNF), responded less well to exposure therapy.

This gene has been implicated previously in treatment response. Basic science studies have convincingly shown that BDNF levels are an important modifier of the therapeutic effects of antidepressants in animal models. Other researchers have made similar findings in a small group of depressed patients treated with the rapid-acting antidepressant ketamine. Low BDNF plasma levels also have been linked to poorer effects of cognitive rehabilitation in schizophrenia. BDNF infused directly into the infralimbic prefrontal cortex in rats was found to extinguish conditioned fear, and BDNF levels were found to modulate the amount of fear extinction.

"Findings are accumulating to suggest that BDNF is an important modifier of the responses to a number of clinical interventions, presumably because BDNF is such an important regulator of neuroplasticity, i.e., the ability of the brain to adapt," said Dr. John Krystal, Editor of Biological Psychiatry.

In this study, researchers from Australia and Puerto Rico teamed up to investigate the influence of the BDNF Val66Met genotype on response to exposure therapy in patients with PTSD. They recruited 55 patients, all of whom participated in an 8-week exposure-based cognitive behavior therapy program.

Exposure therapy is currently the most effective treatment for PTSD, although it does not work for everyone. This type of therapy is delivered over multiple one-on-one sessions with a trained therapist, with a goal of reducing patients' fear and anxiety.

They found that patients with the Met-66 allele of BDNF, compared with patients with the Val/Val allele, showed poorer response to exposure therapy.

"This paper reflects an important and significant advance, in translating recent ground-breaking findings in animal and human neuroscience into clinically anxious populations," said first author Dr. Kim Felmingham.

She added, "Findings from this study support a widely held, but largely untested, hypothesis that extinction is necessary for exposure therapy. It also provides evidence that genotypes influence response to cognitive behavior therapy."

This finding supports prior evidence and highlights the importance of considering genotypes as potential predictor variables in clinical trials of exposure therapy.

### The article is "The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Predicts Response to Exposure Therapy in Posttraumatic Stress Disorder" by Kim L. Felmingham, Carol Dobson-Stone, Peter R. Schofield, Gregory J. Quirk, and Richard A. Bryant (doi: 10.1016/j.biopsych.2012.10.033). The article appears in Biological Psychiatry, Volume 73, Issue 11 (June 1, 2013), published by Elsevier.

Notes for Editors Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Kim Felmingham at Kim.Felmingham@utas.edu.au.

The authors' affiliations, and disclosures of financial and conflicts of interests are available in the article.

John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.

About Biological Psychiatry Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.

The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.

Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 129 Psychiatry titles and 16th out of 243 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2011 Impact Factor score for Biological Psychiatry is 8.283.

About Elsevier Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

ELSE PRESS RELEASES FROM THIS DATE:

How to stop a trunk and start a tail? The leg has the key

2013-06-11

One of the most remarkable anatomical differences among vertebrate bodies is the relative size of their neck, trunk and tail. This can be illustrated by comparing the bodies of a typical snake and of a long tailed lizard. They are both very long and superficially similar. However, most of the snake's body is a trunk full with organs of the digestive, excretory and reproductive systems, whereas the largest part of the lizard's body is a muscular tail. These different body plans are genetically determined during embryonic development. In the latest issue of the journal Developmental ...

Nanofiber sensor detects diabetes or lung cancer faster and easier

2013-06-11

Daejeon, Republic of Korea, June 11, 2013 -- Today's technological innovation enables smartphone users to diagnose serious diseases such as diabetes or lung cancer quickly and effectively by simply breathing into a small gadget, a nanofiber breathing sensor, mounted on the phones. Il-Doo Kim, Associate Professor of Materials Science and Engineering Department at the Korea Advanced Institute of Science and Technology (KAIST), and his research team have recently published a cover paper entitled "Thin-Wall Assembled SnO2 Fibers Functionalized by Catalytic Pt Nanoparticles ...

Scientists discover new layer of the human cornea

2013-06-11

Scientists at The University of Nottingham have discovered a previously undetected layer in the cornea, the clear window at the front of the human eye. The breakthrough, announced in a study published in the academic journal Ophthalmology, could help surgeons to dramatically improve outcomes for patients undergoing corneal grafts and transplants. The new layer has been dubbed the Dua's Layer after the academic Professor Harminder Dua who discovered it. Professor Dua, Professor of Ophthalmology and Visual Sciences, said: "This is a major discovery that will mean that ...

Asian cinema reignites smoking in movies debate

2013-06-11

A University of Adelaide expert says that while the war against smoking in Hollywood movies has been largely won, Asian cinema represents the next major battleground for anti-smoking and anti-cancer groups. Dr Peter Pugsley, Senior Lecturer in Media at the University of Adelaide, says that as smoking rates have been rising in Asia, so too has the depiction of smoking in Asian cinema. Dr Pugsley is the author of a new book on contemporary Asian cinema being published this month. He is also the author of a paper published recently in Continuum: Journal of Media & Cultural ...

Obesity can be predicted from infancy, CWRU researchers find

2013-06-11

Infants as young as two months old already exhibit growth patterns that can predict the child's weight by age 5, according to researchers at Case Western Reserve University's Frances Payne Bolton School of Nursing and Tennessee State University. "Almost from birth, we quickly saw this growth pattern emerge in our curves and growth charts for weight over height," said Susan Ludington, the study's lead investigator and the Carl W. and Margaret David Walter Professor of Pediatric Nursing at Case Western Reserve. Analyzing well-child records, normal-weight babies with a ...

Identification of animal disease-transmission agents based on social networks tools

2013-06-11

Spanish and US scientists have successfully identified animal species that can transmit more diseases to humans by using mathematical tools similar to those applied to the study of social networks like Facebook or Twitter. Their research—recently published in the prestigious journal PNAS—describes how parasite-primate interactions transmit diseases like malaria, yellow fever or AIDS to humans. Their findings could make an important contribution to predicting the animal species most likely to cause future pandemics. Professor José María Gómez of the University of Granada ...

Stem cells reach standard for use in drug development

2013-06-11

Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments. Medical Research Council scientists at the University of Edinburgh have been able to generate cells in the laboratory that reach the gold standard required by the pharmaceutical industry to test drug safety. The researchers used stem cell technology to generate liver cells – which help our bodies to process drugs. They found that the cells were equally effective, reaching the same standard, as ...

American Chemical Society podcast: The first caffeine-'addicted' bacteria

2013-06-11

The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes bacteria that are "addicted" to caffeine in a way that promises practical uses ranging from decontamination of wastewater to bioproduction of medications for asthma. Based on a report by Jeffrey Barrick, Ph.D., and colleagues in the journal ACS Synthetic Biology, the new podcast is available without charge at iTunes and from http://www.acs.org/globalchallenges. Some people may joke about living on caffeine, but scientists now have ...

Background mortality rates key to accurate reporting of vaccine safety risks

2013-06-11

San Diego, CA, June 11, 2013 – In a study using the Vaccine Safety Datalink (VSD), investigators analyzed four years of data and determined that background mortality rates (rates of death irrespective of cause) are crucial in interpreting the numbers of deaths following vaccination. The VSD mortality rate following immunization is lower than the general US population mortality rate, and the causes of death are similar. These background rates can be used in communications to the public about vaccine safety risks, reports the American Journal of Preventive Medicine. Public ...

Why is my baby hospitalized? Many moms in under-developed countries don't know the answer

2013-06-11

ANN ARBOR, Mich. — Mothers in low-income countries may not understand why their babies are hospitalized after delivery, putting sick newborns at higher risk of health problems and death after being released from the hospital, a new study shows. Forty percent of participating mothers in Ghana with sick infants had no understanding of why their child was in the hospital and another 28 percent had only partial understanding, according to the University of Michigan Health System study that appears in Paediatrics and International Child Health Journal. One-third of the women ...

Labor market immigrants moving to Germany are less likely to make their first choice of residence in regions where xenophobic attitudes, measured by right-wing party support and xenophobic violence, a

Lots of screentime in toddlers is linked with worse language skills, but educational content and screen use accompanied by adults might help, per study across 19 Latin American countries

The early roots of carnival? Research reveals evidence of seasonal celebrations in pre-colonial Brazil

Meteorite discovery challenges long-held theories on Earth’s missing elements

[Press-News.org] Posttraumatic stress disorder treatment: Genetic predictor of response to exposure therapy
From a new study in Biological Psychiatry

Posttraumatic stress disorder treatment: Genetic predictor of response to exposure therapy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: